Liu Xiaoqi, Xiao Hai, Luo Mingxia, Meng Junpeng, Zhong Lin, Wu Tao, Zhao Yongxia, Wu Faming, Xie Jian
Department of Pharmacognosy, Zunyi Medical University, Zunyi, China.
Maternal and Child Health Carelhospita, Zunyi, China.
Front Pharmacol. 2024 Apr 5;15:1328977. doi: 10.3389/fphar.2024.1328977. eCollection 2024.
Wight et Arn. Is a traditional Chinese herbal medicine used by the Gelao nationality in southwest China, has been historically applied to treat various gastrointestinal disorders. Despite its traditional usage, scientific evidence elucidating its efficacy and mechanisms in treating ulcerative colitis (UC) remains sparse. This study aimed to determine the quality and chemical composition of and to identify its potential therapeutic targets and mechanisms in acetic acid-induced ulcerative colitis (UC) rats through integrated approaches. Morphological and microscopic characteristics, thin layer chromatography (TLC) identification, and quantitative analysis of were performed. UPLC-Q-TOF-MS, network pharmacology, and molecular docking were used to identify its chemical composition and predict its related targets in UC. Furthermore, a rat model was established to evaluate the therapeutic effect and potential mechanism of on UC. Microscopic identification revealed irregular and radial arrangement of the xylem in , with a light green cross-section and large medullary cells. UPLC-Q-TOF-MS analysis detected and analyzed 570 metabolites, including flavonoids, coumarins, and terpenoids. Network pharmacology identified 12 effective components and 176 target genes, with 96 common targets for -UC, including quercetin, luteolin, and nobiletin as key anti-inflammatory components. GO and KEGG revealed the potential involvement of their targets in RELA, JUN, TNF, IKBKB, PTGS2, and CHUK, with action pathways such as PI3K-Akt, TNF, IL-17, and apoptosis. Molecular docking demonstrated strong affinity and binding between these key components (quercetin, luteolin, and nobiletin) and the key targets of the pathway, including JUN and TNF. Treatment with improved body weight loss, the disease activity index, and colonic histological damage in UC rats. also modulated the levels of IL-2 and IL-6 in UC rats, reduced the expression of pro-inflammatory cytokines such as IL-6, MAPK8, TNF-α, CHUK, and IKBKB mRNA, and decreased the expression of TNF, IKBKB, JUN, and CHUK proteins in the colon of UC rats, thereby reducing inflammation and alleviating UC symptoms. exerts its protective effect on UC by reducing the expression of proinflammatory cytokines and inhibiting inflammation, providing scientific evidence for its traditional use in treating gastrointestinal diseases. This study highlights the potential of as a natural therapeutic agent for UC and contributes to the development of novel medicines for UC treatment.
Wight et Arn.是中国西南部仡佬族使用的一种传统中草药,历史上一直用于治疗各种胃肠道疾病。尽管有传统用法,但阐明其治疗溃疡性结肠炎(UC)的疗效和机制的科学证据仍然稀少。本研究旨在通过综合方法确定Wight et Arn.的质量和化学成分,并确定其在乙酸诱导的溃疡性结肠炎(UC)大鼠中的潜在治疗靶点和机制。进行了形态学和微观特征、薄层色谱(TLC)鉴定以及Wight et Arn.的定量分析。采用超高效液相色谱-四极杆飞行时间质谱(UPLC-Q-TOF-MS)、网络药理学和分子对接来鉴定其化学成分并预测其在UC中的相关靶点。此外,建立大鼠模型以评估Wight et Arn.对UC的治疗效果和潜在机制。微观鉴定显示Wight et Arn.中木质部呈不规则放射状排列,横截面呈浅绿色,髓细胞大。UPLC-Q-TOF-MS分析检测并分析了570种代谢物,包括黄酮类、香豆素类和萜类。网络药理学鉴定出12种有效成分和176个靶基因,Wight et Arn.-UC有96个共同靶点,包括槲皮素、木犀草素和川陈皮素作为关键抗炎成分。基因本体论(GO)和京都基因与基因组百科全书(KEGG)揭示其靶点可能参与RELA、JUN、TNF、IKBKB、PTGS2和CHUK,作用途径如PI3K-Akt、TNF、IL-17和凋亡。分子对接表明这些关键成分(槲皮素、木犀草素和川陈皮素)与该途径的关键靶点(包括JUN和TNF)之间具有强亲和力和结合。Wight et Arn.治疗改善了UC大鼠的体重减轻、疾病活动指数和结肠组织学损伤。Wight et Arn.还调节了UC大鼠中IL-2和IL-6的水平,降低了促炎细胞因子如IL-6、MAPK8、TNF-α、CHUK和IKBKB mRNA的表达,并降低了UC大鼠结肠中TNF、IKBKB、JUN和CHUK蛋白的表达,从而减轻炎症并缓解UC症状。Wight et Arn.通过降低促炎细胞因子的表达和抑制炎症对UC发挥保护作用,为其治疗胃肠道疾病的传统用途提供了科学证据。本研究突出了Wight et Arn.作为UC天然治疗剂的潜力,并有助于开发用于UC治疗的新型药物。